Cancer Advisor

Ivermectin and fenbendazole, originally developed as antiparasitic drugs, are sparking hope in the fight against cancer, fueled by inspiring stories like those shared by actor  Mel Gibson on The Joe Rogan Experience , where he celebrated friends’ remarkable recoveries. While these medications aren’t yet standard cancer treatments, early research is uncovering exciting potential. Scientists are encouraged by promising lab studies and are calling for more clinical trials to confirm their effectiveness and ensure safe use in humans, paving the way for innovative, accessible therapies that could transform lives. Introduction and Context According to a January 22, 2025 fact-check article by AFP: "The anti-parasitic drugs ivermectin and fenbendazole are not currently recommended for cancer, but posts spread across social media touting the medications after actor  Mel Gibson claimed on the Joe Rogan Experience  that they cured his friends' cases of the disease. Oncology ex...

Executive Summary : Modern oncology relies heavily on the immune system—specifically T-cells and Natural Killer (NK) cells—to identify and destroy mutated cells before they turn into tumors. While internet discussions have popularized the phrase "turbo cancer" to link rising cancer rates to post-2020 events like mRNA vaccines, global oncological data tells a different story. Long-term public health statistics prove that the real rise in early-onset cancers began decades ago, driven by chronic inflammation, ultra-processed diets, and environmental exposures. Credit: Statista The Biological Shield: How Your Immune System Attacks Cancer Every single day, your body undergoes genomic mutations. The reason these mutations rarely develop into clinical disease is due to immune surveillance. Your immune system acts as an internal bioshield using a highly coordinated two-prong attack: Natural Killer (NK) Cells: These are the rapid-response infantry of the innate immune system....